Review: taking Levofloxacin and Cefixime together


Summary

Drug interactions are reported among people who take Levofloxacin and Cefixime together. This review analyzes the effectiveness and drug interactions between Levofloxacin and Cefixime. It is created by eHealthMe based on reports of 19 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Levofloxacin and Cefixime >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Levofloxacin

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is often used in pneumonia. (latest outcomes from Levofloxacin 15,349 users)

Cefixime

Cefixime has active ingredients of cefixime. It is often used in urinary tract infection. (latest outcomes from Cefixime 520 users)

On Aug, 28, 2016

19 people who take Levofloxacin, Cefixime are studied.


Number of reports submitted per year:

Levofloxacin and Cefixime drug interactions.

Drug effectiveness over time:

Levofloxacin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Cefixime:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Levofloxacin:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Cefixime:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Levofloxacin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Cefixime:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • gastrointestinal haemorrhage
  • sudden death
  • cardiac disorder
  • haemorrhage
  • hypoxia
  • pyrexia
  • renal failure acute
  • tendonitis
5 - 10 years:
  • bronchitis acute viral
  • gastritis - acute
  • potassium - low
  • typhoid fever
not specified:
  • cough
  • pyrexia
  • po2 decreased
  • appendicitis
  • colitis pseudomembranous
  • febrile neutropenia
  • gastroenteritis
  • hypotension
  • infusion related reaction
  • metastases to bone

Most common drug interactions by gender *:

female:
  • gastrointestinal haemorrhage
  • bronchitis acute viral
  • gastritis - acute
  • potassium - low
  • typhoid fever
  • abdominal pain upper
  • anaphylactoid reaction
  • angioneurotic oedema
  • asthenia
  • cough
male:
  • pyrexia
  • cardiac disorder
  • cough
  • haemorrhage
  • hypoxia
  • po2 decreased
  • appendicitis
  • colitis pseudomembranous
  • febrile neutropenia
  • gastroenteritis

Most common drug interactions by age *:

10-19:
  • appendicitis
  • febrile neutropenia
  • gastroenteritis
  • hypotension
  • infusion related reaction
  • sepsis
  • serum sickness
  • abdominal pain
  • drug toxicity
  • therapeutic agent toxicity
20-29:
  • bronchitis acute viral
  • gastritis - acute
  • potassium - low
  • typhoid fever
40-49:
  • abdominal pain upper
  • anaphylactoid reaction
  • angioneurotic oedema
  • colitis pseudomembranous
  • cough
  • monoparesis
  • oedema upper limb
  • pruritus
  • retching
60+:
  • gastrointestinal haemorrhage
  • metastases to bone
  • prostatitis
  • renal failure acute
  • pyrexia
  • cardiac disorder
  • cough
  • haemorrhage
  • hypoxia
  • po2 decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Levofloxacin and Cefixime?

Can you answer these questions?

More questions for: Levofloxacin, Cefixime

You may be interested in these reviews

More reviews for: Levofloxacin, Cefixime

On eHealthMe, Levofloxacin (levofloxacin; sodium chloride) is often used to treat pneumonia. Cefixime (cefixime) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.